Efficacy of bevacizumab combined with chemotherapy in the treatment of HER2-negative metastatic breast cancer: a network meta-analysis

BACKGROUND: It is not known what combination of bevacizumab and chemotherapy agents is the best therapeutic regimen. Comparative study results among the efficacies of bevacizumab plus chemotherapy remain controversial in patients with HER2-negative metastatic breast cancer. METHODS: We searched Pubm...

Descripción completa

Detalles Bibliográficos
Autores principales: Sun, Zhengwu, Lan, Xiaoyan, Xu, Shizhao, Li, Shen, Xi, Yalin
Formato: Online Artículo Texto
Lenguaje:English
Publicado: BioMed Central 2020
Materias:
Research Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7057674/
https://www.ncbi.nlm.nih.gov/pubmed/32131770
http://dx.doi.org/10.1186/s12885-020-6674-1

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7057674/
https://www.ncbi.nlm.nih.gov/pubmed/32131770
http://dx.doi.org/10.1186/s12885-020-6674-1

Ejemplares similares